BioSpace News Archive

Smith+Nephew, the global medical technology business, announces the successful introduction of its new field sales operations and inventory automation solution in the US in partnership with Movemedical.

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced positive topline results from its LiFT (“Liver Fat intervention with oral Testosterone”) Phase 2 clinical study (NCT04134091), investigating LPCN 1144 in biopsy-confirmed non-cirrhotic non-alcoholic steatohepatitis (“NASH”) male subjects

Nucleic acid sequence-based amplification is a new isothermal, transcription-based amplification method specially designed to amplify the RNA.

The need for freeze-drying has become a necessity across the food and pharmaceutical industry, and this factor has driven demand within the global lyophilization equipment and services market.

The global research antibodies market is predicted to be a progressive one over the forecast period. The exceptional physiological properties of antibodies make them sought-after for cell research.

Growing preference for minimally invasive surgeries (MIS) may prove as a prime reason for the growth of the arterial stents market. An increasing number of patients with more than 70 percent of artery blockage is pushing the arterial stents market toward growth.

Unwavering prevalence of cardiac conditions such as flutter, atrial fibrillation, and arrhythmia has driven the adoption of medical procedures such as ablation and electrophysiology study.

Conventional surgical procedures are time consuming and less accurate, with risk of hazards to nearby nonsurgical area involved.

According to the study, the demand for platelet-rich plasma from hospitals will be worthUS$ 184 Mn in 2022, with demand rising at over 10% through 2022.

BetterLife Pharma Inc. is pleased to provide an overview of the Company’s primary plans for this calendar year to develop 3 novel therapeutic products, each addressing significant unmet needs with multi-billion dollar market potential.